Biohaven Pharmaceutical Holding Company
Tracked across 3 events · 18 articles · First seen Jul 25, 2025 · Last active Sep 09, 2025
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Biohaven Pharmaceutical Holding Company is facing a federal securities class action lawsuit for allegedly making false and misleading statements regarding its drug candidates, troriluzole and BHV-7000. Its stock price fell significantly after the FDA extended the PDUFA date for troriluzole.
Jul 25, 2025 · 6 articles
Regulatory
Impact: Biohaven Pharmaceutical Holding Company is the target of a class action lawsuit due to alleged false statements and concealment regarding its product candidates, troriluzole and BHV-7000, which negatively impacted its business and financial condition.
Jul 25, 2025 · 6 articles
Business
Impact: Biohaven Pharmaceutical Holding Company is the defendant in a securities class action lawsuit, accused of making false and misleading statements regarding its drug prospects.
Aug 15, 2025 · 6 articles
ERGEN INTELLIGENCE
Track Biohaven Pharmaceutical Holding Company live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard